The Fetal Medicine Foundation 16th World Congress in Fetal Medicine, Ljubljana, Slovenia
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • High NT
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidney
    • Skeleton
    • Tumors
    • Placenta
    • Syndromes
    • Other
    • All
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infections
  • Labor / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

Aneuploidies

  1. A case of early recurrent pregnancy loss caused by paternal translocation t(3;8)(q13;q24) View pdf
  2. A case of triploidy View pdf
  3. A case of triploidy and non invasive prenatal testing View pdf
  4. A case of trisomy 18 with isolated Rocker bottom foot View pdf
  5. A case of Turner’s Syndrome View pdf
  6. Absent/ hypoplastic nasal bone as an isolated marker at the 18 – 24 weeks’ scan View pdf
  7. Amniocentesis as a prenatal diagnostic method for detecting aneuploidies. View pdf
  8. Anxiety and invasive testing View pdf
  9. Assessment of multiple quantitative fluorescence PCR technique for common chromosome aneuploidies View pdf
  10. Challenges and Potentials in Prenatal Diagnosis of Genetic Disorders View pdf
  11. Chromosomal abnormalities in women having amniocentesis for increased maternal age View pdf
  12. Clinodactyly associated with Trisomy 21: A case report View pdf
  13. Combined use of cytogenetic and SNP array in prenatal diagnostics of chromosomal abnormalities View pdf
  14. Cytogenetic analysis of 1372 intellectually disabled children View pdf
  15. Ductus venosus pulsatility index in the screening protocol for trisomy 21 at 11-13 weeks View pdf
  16. Early amniocentesis vs. transabdominal chorionic villus sampling for prenatal diagnosis View pdf
  17. Evaluation of twelve years of combined screening for aneuploidies View pdf
  18. First trimester free-Beta-hCG and PAPP-A median correction factors for Mexican population View pdf
  19. Follow up assessment of absent nasal bone in the second trimester View pdf
  20. Genetic characterization of sixteen 46,XX males with disorders of sex development View pdf
  21. Implementation of first trimester combined testin a local practice View pdf
  22. Importance of isolated ultrasound markers at the 18 – 24 weeks’ scan View pdf
  23. Influence of first trimester biochemistry methodology on detection rate in screening for trisomy 21 View pdf
  24. Isolated Ultrasound Marker in the First Trimester – Is Invasive Testing Justified? View pdf
  25. Methylation-specific quantitative real-time PCR in detection of fetal trisomy 21 View pdf
  26. Nasal bone in screening for T21 at 11-13+6 weeks of gestation - a multicenter study View pdf
  27. New mixture models of markers for trisomies in the first trimester screening View pdf
  28. NT, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: meta-analysis View pdf
  29. Prenatal BACs-on-Beads in the detection of common chromosomal abnormalities and microdeletions View pdf
  30. Prenatal screening for chromosomal abnormalities in the period 2007-2016. View pdf
  31. Qualitative and quantitative ductus venosus flow assessment in screening for trisomy 18 and 13 View pdf
  32. Quality control of nuchal translucency measurements in Hung Vuong hospital, Vietnam View pdf
  33. Reference range of fetal NT thickness in Iran View pdf
  34. Reference ranges for fetal nasal bone in screening for chromosomal abnormalities at 11-13 weeks View pdf
  35. Reference ranges for fetal prenasal thickness in screening for chromosomal abnormalities at 16-24 weeks View pdf
  36. Review of 1604 amniocentesis performed in the period 2007-2016 View pdf
  37. Single umbilical artery, autosomal trisomies: First or second trimester detection? View pdf
  38. SLC25A13 genetic analysis and prenatal diagnosis of citrin deficiency in 20 families View pdf
  39. Subsequent trisomy 13 pregnancies of parents with normal karyotype View pdf
  40. The absence of nasal bones in the first trimester ultrasound scan in fetal trisomies View pdf
  41. The incidence of chromosomal anomalies in fetuses with bilateral pyelectasis View pdf
  42. Use of low pass whole genome sequencing in clinical cytogenetics, pathogenic cnv detection View pdf
  43. Women's knowledge and concerns about invasive prenatal testing View pdf
2275197621622188223019522105230119261907213921692006183621902112229622322287194322481951214319501893217421202050197521522145204919101966196421442119212818952298209517682302
© 2017 The Fetal Medicine Foundation